Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Validation of the REMINDER Dementia Risk Reduction Program — Stella

Home/Healthy Aging/Validation of the REMINDER Dementia Risk Reduction Program

View on ClinicalTrials.gov

Recruiting

Back to Healthy Aging trials

Validation of the REMINDER Dementia Risk Reduction Program

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Portugal

Faculty of Psychology and Educational Sciences, Coimbra

Key details

Sponsor

University of Coimbra

Collaborators

Fundação para a Ciência e a Tecnologia

Enrollment target

~400 participants

Started

April 2022

Primary completion

May 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

60 Years – 75 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.